Sherman Oaks, CA · Founded 2015 · Privately Held (backing)
Developer of nucleotide metabolism drugs designed to provide treatment for cancer and autoimmune diseases. Trethera is based in Sherman Oaks, CA and was founded in 2015. Its last reported valuation was $13.1 million in Apr 2019. It has raised $35 million across 7 recorded rounds; the latest was a $250,000 seed round in Apr 2025.
Last reported valuation
$13.1M
Oct 2026
Priced at
—
Total raised
$35.0M
Last round
Seed Round
Apr 2025
Team — not yet on record
No current team members for Trethera are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Trethera with a free account
·Watch Trethera: the Monday email on marks, rounds and moves
